Discontinued — last reported Q4 '25
Current Assets
Prepaid & Other Current
Regeneron Pharmaceuticals Prepaid & Other Current increased by 30.8% to $620.90M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 32.4%, from $468.90M to $620.90M. Over 5 years (FY 2020 to FY 2025), Prepaid & Other Current shows an upward trend with a 24.2% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ4 2014
Last reportedQ4 2025
How to read this metric
Significant changes usually reflect timing differences in vendor payments or shifts in short-term operational requirements.
Detailed definition
Payments made in advance for goods or services to be received within one year, along with other miscellaneous short-term...
Peer comparison
Usually a small percentage of total assets for tech hardware firms, though it can spike during major production ramp-ups.
Metric ID:
prepaid_and_other_current_assetsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $444.30M | $482.00M | $332.40M | $424.90M | $583.60M | $446.40M | $411.20M | $406.20M | $366.30M | $574.70M | $386.60M | $414.90M | $681.90M | $412.00M | $349.20M | $468.90M | $574.30M | $595.60M | $474.80M | $620.90M |
| QoQ Change | — | +8.5% | -31.0% | +27.8% | +37.3% | -23.5% | -7.9% | -1.2% | -9.8% | +56.9% | -32.7% | +7.3% | +64.4% | -39.6% | -15.2% | +34.3% | +22.5% | +3.7% | -20.3% | +30.8% |
| YoY Change | — | — | — | — | +31.4% | -7.4% | +23.7% | -4.4% | -37.2% | +28.7% | -6.0% | +2.1% | +86.2% | -28.3% | -9.7% | +13.0% | -15.8% | +44.6% | +36.0% | +32.4% |
Range$332.40M – $681.90M
CAGR+7.3%
Avg YoY Growth+11.8%
Median YoY Growth+7.6%
Prepaid & Other Current at Other Companies
Frequently Asked Questions
- What is Regeneron Pharmaceuticals's prepaid & other current?
- Regeneron Pharmaceuticals (REGN) reported prepaid & other current of $620.90M in Q1 2026.
- How has Regeneron Pharmaceuticals's prepaid & other current changed year-over-year?
- Regeneron Pharmaceuticals's prepaid & other current increased by 32.4% year-over-year, from $468.90M to $620.90M.
- What is the long-term trend for Regeneron Pharmaceuticals's prepaid & other current?
- Over 5 years (2020 to 2025), Regeneron Pharmaceuticals's prepaid & other current has grown at a 24.2% compound annual growth rate (CAGR), from $160.80M to $474.80M.
- What does prepaid & other current mean?
- Bills paid in advance and other small assets that will be used up within the next twelve months.